Biodesix press release: Wellmark BCBS of Iowa and South Dakota provides coverage for VeriStrat® Test
Horizon Blue Cross Blue Shield (BCBS) of New Jersey has determined that the VeriStrat® proteomic test is now considered a medically necessary benefit for members with advanced NSCLC.
Biodesix announced that the VeriStrat® test is now considered a medically necessary benefit by Aetna Corporation.
CE Mark clears Biodesix to make VeriStrat results available to physicians in the European Union and other countries recognizing the CE Mark.